Techne Corp (NASDAQ:TECH)
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
ibd
Recs
Biotech is back in fashion.
Recs
CONTINUE TO GROW
Recs
Why spend money inventing new drugs when you can make a pile of money supplying those who do?
Recs
Biotechnology is an advancing field and R&D has continued to outperform in Europe due to the medical field requiring better instruments and tech and Techne Corp delivering consistently.
Recs
health & tech, gotta go up
Recs
management focus
Recs
I have a couple reasons for liking this company, but mainly it fits into my whole "I love Minnesota companies" mantra.
Recs
Great management ,steady earnings growth; a big stock buyback in progress, and one portfolio company preparing an IPO for big gains.
Recs
VALUE LINES - TIMELY STOCKS IN TIMELY INDUSTRIES
Recs
Techne makes the products that biotech and pharmaceutical companies use for their research (also other medical research). It is an unique field.
Recs
started a terrible downturn from a technical standpoing
Recs
A solid company capable of weathering out any volatility of the market
Recs
Good acquisition candidate
Recs
Great company with less risk than most biotechs.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 35 of 35 : « Previous 1 2